News - Page 96 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Field Trip Announces Closing of Plan of Arrangement and $19.9 Million Private Placement Financing

Field Trip Announces Closing of Plan of Arrangement and $19.9 Million Private Placement Financing

Post published:August 13, 2022
Post category:Press Release

Read more about the article PsyBio Therapeutics Strengthens IP Portfolio through Filing of Data to Support Previously Submitted Provisional Biosynthetic Production Patent Application

PsyBio Therapeutics Strengthens IP Portfolio through Filing of Data to Support Previously Submitted Provisional Biosynthetic Production Patent Application

Post published:August 12, 2022
Post category:Press Release

Read more about the article Psychedelic Bulletin #114 – Lawsuit Alleges Compass Stole Trade Secrets; MindMed CMO Turns Activist Shareholder; California Decrim. Bill Tentatively Clears Hurdle

Psychedelic Bulletin #114 – Lawsuit Alleges Compass Stole Trade Secrets; MindMed CMO Turns Activist Shareholder; California Decrim. Bill Tentatively Clears Hurdle

Post published:August 12, 2022
Post category:Psychedelic Bulletin

Read more about the article Optimi Health Unveils Canada’s First Natural Therapeutic Psilocybin Product For Approved Patients

Optimi Health Unveils Canada’s First Natural Therapeutic Psilocybin Product For Approved Patients

Post published:August 12, 2022
Post category:Press Release

Read more about the article MindMed Strengthens Board with Appointment of Two New Independent Directors

MindMed Strengthens Board with Appointment of Two New Independent Directors

Post published:August 12, 2022
Post category:Press Release

Read more about the article Opinions | Hallucinations of Meaning: If you can lie, so can psychedelics

Opinions | Hallucinations of Meaning: If you can lie, so can psychedelics

Post published:August 12, 2022
Post category:Opinions

Read more about the article MYDECINE INNOVATIONS GROUP ANNOUNCES RESIGNATION OF DIRECTORS

MYDECINE INNOVATIONS GROUP ANNOUNCES RESIGNATION OF DIRECTORS

Post published:August 12, 2022
Post category:Press Release

Read more about the article MindMed Reports Second Quarter 2022 Financial Results and Business Highlights

MindMed Reports Second Quarter 2022 Financial Results and Business Highlights

Post published:August 11, 2022
Post category:Press Release

Read more about the article Psilera’s New Compounds Show Potential for Significant Treatment Improvement in Depression and Neurodegenerative Disorders

Psilera’s New Compounds Show Potential for Significant Treatment Improvement in Depression and Neurodegenerative Disorders

Post published:August 10, 2022
Post category:Press Release

Read more about the article Mindset Pharma CEO, James Lanthier, Issues Letter to Shareholders

Mindset Pharma CEO, James Lanthier, Issues Letter to Shareholders

Post published:August 9, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.